234 related articles for article (PubMed ID: 11284462)
1. Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Rizatriptan Protocol 046 Study Group.
Goldstein J; Ryan R; Jiang K; Getson A; Norman B; Block GA; Lines C
Headache; 1998; 38(10):737-47. PubMed ID: 11284462
[TBL] [Abstract][Full Text] [Related]
2. Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine.
Loder E; Brandes JL; Silberstein S; Skobieranda F; Bohidar N; Wang L; Boyle D; Kolodny A; Guerra F; Santanello N; Johnson-Pratt L;
Headache; 2001 Sep; 41(8):745-53. PubMed ID: 11576197
[TBL] [Abstract][Full Text] [Related]
3. Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group.
Tfelt-Hansen P; Teall J; Rodriguez F; Giacovazzo M; Paz J; Malbecq W; Block GA; Reines SA; Visser WH
Headache; 1998; 38(10):748-55. PubMed ID: 11284463
[TBL] [Abstract][Full Text] [Related]
4. Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine.
Pascual J; Bussone G; Hernandez JF; Allen C; Vrijens F; Patel K;
Eur Neurol; 2001; 45(4):275-83. PubMed ID: 11385269
[TBL] [Abstract][Full Text] [Related]
5. Comparison of rizatriptan 5 mg and 10 mg tablets and sumatriptan 25 mg and 50 mg tablets.
Kolodny A; Polis A; Battisti WP; Johnson-Pratt L; Skobieranda F;
Cephalalgia; 2004 Jul; 24(7):540-6. PubMed ID: 15196296
[TBL] [Abstract][Full Text] [Related]
6. Oral therapy for migraine: comparisons between rizatriptan and sumatriptan. A review of four randomized, double-blind clinical trials.
Tfelt-Hansen P; Ryan RE
Neurology; 2000; 55(9 Suppl 2):S19-24. PubMed ID: 11089515
[TBL] [Abstract][Full Text] [Related]
7. Rizatriptan: a review of its efficacy in the management of migraine.
Dooley M; Faulds D
Drugs; 1999 Oct; 58(4):699-723. PubMed ID: 10551439
[TBL] [Abstract][Full Text] [Related]
8. Comparison of rizatriptan and other triptans on stringent measures of efficacy.
Adelman JU; Lipton RB; Ferrari MD; Diener HC; McCarroll KA; Vandormael K; Lines CR
Neurology; 2001 Oct; 57(8):1377-83. PubMed ID: 11673575
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.
Seeburger JL; Taylor FR; Friedman D; Newman L; Ge Y; Zhang Y; Hustad CM; Lasorda J; Fan X; Hewitt D; Ho T; Connor KM
Cephalalgia; 2011 May; 31(7):786-96. PubMed ID: 21078681
[TBL] [Abstract][Full Text] [Related]
10. Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis.
Lipton RB; Pascual J; Goadsby PJ; Massiou H; McCarroll KA; Vandormael K; Jiang K; Lines CR
Headache; 2001 Sep; 41(8):754-63. PubMed ID: 11576198
[TBL] [Abstract][Full Text] [Related]
11. Restoring migraine sufferers' ability to function normally: a comparison of rizatriptan and other triptans in randomized trials.
Bussone G; D'Amico D; McCarroll KA; Gerth W; Lines CR
Eur Neurol; 2002; 48(3):172-7. PubMed ID: 12373035
[TBL] [Abstract][Full Text] [Related]
12. Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group.
Visser WH; Terwindt GM; Reines SA; Jiang K; Lines CR; Ferrari MD
Arch Neurol; 1996 Nov; 53(11):1132-7. PubMed ID: 8912486
[TBL] [Abstract][Full Text] [Related]
13. A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Rizatriptan Multiple Attack Study Group.
Kramer MS; Matzura-Wolfe D; Polis A; Getson A; Amaraneni PG; Solbach MP; McHugh W; Feighner J; Silberstein S; Reines SA
Neurology; 1998 Sep; 51(3):773-81. PubMed ID: 9748025
[TBL] [Abstract][Full Text] [Related]
14. Rizatriptan: pharmacological differences from sumatriptan and clinical results.
Lines CR; McCarroll KA; Visser WH
Curr Med Res Opin; 2001; 17 Suppl 1():s54-8. PubMed ID: 12463279
[TBL] [Abstract][Full Text] [Related]
15. Patient satisfaction with rizatriptan versus other triptans: direct head-to-head comparisons.
Gerth WC; McCarroll KA; Santanello NC; Vandormael K; Zhang Q; Mannix LK
Int J Clin Pract; 2001 Oct; 55(8):552-6. PubMed ID: 11695077
[TBL] [Abstract][Full Text] [Related]
16. Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Rizatriptan 022 Study Group.
Teall J; Tuchman M; Cutler N; Gross M; Willoughby E; Smith B; Jiang K; Reines S; Block G
Headache; 1998 Apr; 38(4):281-7. PubMed ID: 9595867
[TBL] [Abstract][Full Text] [Related]
17. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study.
Winner P; Lewis D; Visser WH; Jiang K; Ahrens S; Evans JK;
Headache; 2002 Jan; 42(1):49-55. PubMed ID: 12005275
[TBL] [Abstract][Full Text] [Related]
18. Sumatriptan (intranasal route of administration) for acute migraine attacks in adults.
Derry CJ; Derry S; Moore RA
Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD009663. PubMed ID: 22336867
[TBL] [Abstract][Full Text] [Related]
19. Oral sumatriptan for acute migraine.
McCrory DC; Gray RN
Cochrane Database Syst Rev; 2003; (3):CD002915. PubMed ID: 12917936
[TBL] [Abstract][Full Text] [Related]
20. Rizatriptan in the treatment of menstrual migraine.
Silberstein SD; Massiou H; Le Jeunne C; Johnson-Pratt L; McCarroll KA; Lines CR
Obstet Gynecol; 2000 Aug; 96(2):237-42. PubMed ID: 10908770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
